Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-24-000073
Filing Date
2024-12-03
Accepted
2024-12-03 11:28:46
Documents
2
Period of Report
2024-12-03

Document Format Files

Seq Description Document Type Size
1 6-K form6kgobletc5safetyrun-in.htm 6-K 18222
2 EX-99.1 gobletcohort5safetyrun-in.htm EX-99.1 25212
  Complete submission text file 0001129928-24-000073.txt   44430
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 241521756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)